A051901: Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
- Title
- Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
- Principal Investigator
- Aulakh, Sonikpreet
- Phase
- I
- Age Group
- Adult
- Applicable Disease Sites
- Brain Cancer
- Lymphoma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Syed Abdul Mannan Shah
- Clinical Research Specialist
- Phone: +1 304-293-1683
- Email: syedabdulmannan.shah@hsc.wvu.edu